Skip to main content

VORINOSTAT PROVIDES PROLONGED SAFETY AND CLINICAL BENEFIT TO PATIENTS WITH ADVANCED CUTANEOUS T-CELL LYMPHOMA (CTCL)

Publication ,  Journal Article
Duvic, M; Olsen, EA; Breneman, D; Pacheco, TR; Parker, S; Vonderheid, EC; Ricker, JL; Rizvi, S; Chen, C; Boileau, K; Gunchenko, A; Geskin, LJ ...
Published in: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
June 1, 2008

Duke Scholars

Published In

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL

EISSN

1592-8721

ISSN

0390-6078

Publication Date

June 1, 2008

Volume

93

Start / End Page

107 / 108

Location

Copenhagen, DENMARK

Publisher

FERRATA STORTI FOUNDATION

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Duvic, M., Olsen, E. A., Breneman, D., Pacheco, T. R., Parker, S., Vonderheid, E. C., … Geskin, L. J. (2008). VORINOSTAT PROVIDES PROLONGED SAFETY AND CLINICAL BENEFIT TO PATIENTS WITH ADVANCED CUTANEOUS T-CELL LYMPHOMA (CTCL). HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 93, 107–108.
Duvic, M., E. A. Olsen, D. Breneman, T. R. Pacheco, S. Parker, E. C. Vonderheid, J. L. Ricker, et al. “VORINOSTAT PROVIDES PROLONGED SAFETY AND CLINICAL BENEFIT TO PATIENTS WITH ADVANCED CUTANEOUS T-CELL LYMPHOMA (CTCL).” HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 93 (June 1, 2008): 107–8.
Duvic M, Olsen EA, Breneman D, Pacheco TR, Parker S, Vonderheid EC, et al. VORINOSTAT PROVIDES PROLONGED SAFETY AND CLINICAL BENEFIT TO PATIENTS WITH ADVANCED CUTANEOUS T-CELL LYMPHOMA (CTCL). HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. 2008 Jun 1;93:107–8.
Duvic, M., et al. “VORINOSTAT PROVIDES PROLONGED SAFETY AND CLINICAL BENEFIT TO PATIENTS WITH ADVANCED CUTANEOUS T-CELL LYMPHOMA (CTCL).” HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, vol. 93, FERRATA STORTI FOUNDATION, June 2008, pp. 107–08.
Duvic M, Olsen EA, Breneman D, Pacheco TR, Parker S, Vonderheid EC, Ricker JL, Rizvi S, Chen C, Boileau K, Gunchenko A, Sanz-Rodriguez C, Geskin LJ. VORINOSTAT PROVIDES PROLONGED SAFETY AND CLINICAL BENEFIT TO PATIENTS WITH ADVANCED CUTANEOUS T-CELL LYMPHOMA (CTCL). HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. FERRATA STORTI FOUNDATION; 2008 Jun 1;93:107–108.

Published In

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL

EISSN

1592-8721

ISSN

0390-6078

Publication Date

June 1, 2008

Volume

93

Start / End Page

107 / 108

Location

Copenhagen, DENMARK

Publisher

FERRATA STORTI FOUNDATION

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology